An examination of the intracellular levels of SMN protein in MEFs derived from the Smn2B/− mouse model of SMA or wildtype mice showed that, as expected, there are significantly reduced levels of SMN protein in the SMA model (Fig. 4A). The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.